Evidera
Sugam Mahajan is a Research Associate III at Evidera since August 2022, with prior experience as a Senior Associate Manager and Associate Manager at Eli Lilly and Company from April 2020 to July 2022. Sugam spent nearly three years at Complete HEOR Solutions (CHEORS) as a Senior Analyst and Analyst from June 2017 to March 2020. Initial experience includes a summer internship at the Center for Economic Studies and Planning (CESP) at JawaharLal Nehru University in 2016, focused on data compilation and trend analysis in state finances, as well as an internship at the Institute of Economic Growth in late 2015, where Sugam wrote reviews on economic articles. Educational qualifications include a Master of Arts in Economics from Bharat Ratana Dr. B. R. Ambedkar University (2015-2017) and a Bachelor of Arts (Honors) in Economics from Shaheed Bhagat Singh College (2012-2015).
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.